Literature DB >> 24809592

Risk factors and surgical management of anastomotic biliary complications after pediatric liver transplantation.

Tom Darius1, Jairo Rivera, Fabio Fusaro, Quirino Lai, Catherine de Magnée, Christophe Bourdeaux, Magdalena Janssen, Philippe Clapuyt, Raymond Reding.   

Abstract

Biliary complications (BCs) still remain the Achilles heel of liver transplantation (LT) with an overall incidence of 10% to 35% in pediatric series. We hypothesized that (1) the use of alternative techniques (reduced size, split, and living donor grafts) in pediatric LT may contribute to an increased incidence of BCs, and (2) surgery as a first treatment option for anastomotic BCs could allow a definitive cure for the majority of these patients. Four hundred twenty-nine primary pediatric LT procedures, including 88, 91, 47, and 203 whole, reduced size, split, and living donor grafts, respectively, that were performed between July 1993 and November 2010 were retrospectively reviewed. Demographic and surgical variables were analyzed, and their respective impact on BCs was studied with univariate and multivariate analyses. The modalities of BC management were also reviewed. The 1- and 5-year patient survival rates were 94% and 90%, 89% and 85%, 94% and 89%, and 98% and 94% for whole, reduced size, split, and living donor liver grafts, respectively. The overall incidence of BCs was 23% (n = 98). Sixty were anastomotic complications [47 strictures (78%) and 13 fistulas (22%)]. The graft type was not found to be an independent risk factor for the development of BCs. According to a multivariate analysis, only hepatic artery thrombosis and acute rejection increased the risk of anastomotic BCs (P < 0.001 and P = 0.003, respectively). Anastomotic BCs were managed primarily with surgical repair in 59 of 60 cases with a primary patency rate of 80% (n = 47). These results suggest that (1) most of the BCs were anastomotic complications not influenced by the type of graft, and (2) the surgical management of anastomotic BCs may constitute the first and best therapeutic option.
© 2014 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2014        PMID: 24809592     DOI: 10.1002/lt.23910

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  7 in total

1.  Biliary Complication in Pediatric Liver Transplantation: a Single-Center 15-Year Experience.

Authors:  Chih-Yang Hsiao; Cheng-Maw Ho; Yao-Ming Wu; Ming-Chih Ho; Rey-Heng Hu; Po-Huang Lee
Journal:  J Gastrointest Surg       Date:  2019-01-10       Impact factor: 3.452

2.  Endoscopic treatment of biliary complications after duct-to-duct biliary anastomosis in pediatric liver transplantation.

Authors:  M Harputluoglu; U Demirel; A R Caliskan; A Selimoglu; Y Bilgic; M Aladag; M A Erdogan; R Dertli; Y Atayan; S Yilmaz
Journal:  Langenbecks Arch Surg       Date:  2019-07-20       Impact factor: 3.445

Review 3.  Biliary complications after pediatric liver transplantation: Risk factors, diagnosis and management.

Authors:  Flavia H Feier; Eduardo A da Fonseca; Joao Seda-Neto; Paulo Chapchap
Journal:  World J Hepatol       Date:  2015-08-28

Review 4.  Global lessons in graft type and pediatric liver allocation: A path toward improving outcomes and eliminating wait-list mortality.

Authors:  Evelyn K Hsu; George V Mazariegos
Journal:  Liver Transpl       Date:  2017-01       Impact factor: 5.799

5.  Living Donor Versus Deceased Donor Pediatric Liver Transplantation: A Systematic Review and Meta-analysis.

Authors:  Arianna Barbetta; Chanté Butler; Sarah Barhouma; Rachel Hogen; Brittany Rocque; Cameron Goldbeck; Hannah Schilperoort; Glenda Meeberg; James Shapiro; Yong K Kwon; Rohit Kohli; Juliet Emamaullee
Journal:  Transplant Direct       Date:  2021-09-20

6.  Hepatolithiasis After Living Donor Liver Transplantation in Pediatric Patients: Mechanism, Diagnosis, Treatment, and Prognosis.

Authors:  Yukihiro Sanada; Yasunaru Sakuma; Yasuharu Onishi; Noriki Okada; Yuta Hirata; Toshio Horiuchi; Takahiko Omameuda; Alan Kawarai Lefor; Naohiro Sata
Journal:  Transpl Int       Date:  2022-02-14       Impact factor: 3.782

7.  Sequential Treatment of Biliary Atresia With Kasai Hepatoportoenterostomy and Liver Transplantation: Benefits, Risks, and Outcome in 393 Children.

Authors:  Roberto Tambucci; Catherine de Magnée; Margot Szabo; Aniss Channaoui; Aurore Pire; Vanessa de Meester de Betzenbroeck; Isabelle Scheers; Xavier Stephenne; Françoise Smets; Etienne M Sokal; Raymond Reding
Journal:  Front Pediatr       Date:  2021-07-07       Impact factor: 3.418

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.